Reuters logo
1 年前
BRIEF-Kura Oncology entered amendment to license agreement with janssen pharmaceutica - SEC filing
2016年6月6日 / 晚上8点37分 / 1 年前

BRIEF-Kura Oncology entered amendment to license agreement with janssen pharmaceutica - SEC filing

June 6 (Reuters) - Kura Oncology Inc

* Entered amendment to license agreement with Janssen Pharmaceutica NV dated December 18, 2014 - SEC filing

* Amendment to expand field of license to all human diseases, disorders/medical conditions

* Amendment to management services agreement with Araxes Pharma LLC to reduce the monthly management fee payable by Araxes to co

* Amendment to agreement with Araxes Pharma to reduce monthly management fee from $100,000/month to $65,000/month effective from April 1,2016 Source text for Eikon: [ID:(1.usa.gov/1suvK2P )] Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below